HIV molecular immunology database

 

Search CTL/CD8+ T-Cell Epitope Database

Found 7 matching records:

Displaying record number 59207

HXB2 Location Gag(147-155)
p24(15-23)
DNA(1228..1254)
Gag Epitope Map
Author Location Gag(147-155)
Epitope ISPRTLNAW Epitope Alignment
ISPRTLNAW epitope logo
Show epitope variants
Epitope Name ISW9
Subtype B
Species (MHC/HLA) human(B*5701)
Immunogen HIV-1 infection
Patient MHC/HLA P1: B*5701; P3: B*5701; P4: B*5701; P5: B*5701; P6: B*5701
Country United States
Experimental methods Other
Keywords elite controllers

Notes

References

Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.


Displaying record number 59208

HXB2 Location Gag(162-172)
p24(30-40)
DNA(1273..1305)
Gag Epitope Map
Author Location Gag(162-172)
Epitope KAFSPEVIPMF Epitope Alignment
KAFSPEVIPMF epitope logo
Show epitope variants
Epitope Name KF11
Subtype B
Species (MHC/HLA) human(B*5701)
Immunogen HIV-1 infection
Patient MHC/HLA P1: B*5701; P6: B*5701
Country United States
Experimental methods Other
Keywords elite controllers

Notes

References

Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.


Displaying record number 59210

HXB2 Location Gag(240-249)
p24(108-117)
DNA(1507..1536)
Gag Epitope Map
Author Location Gag(240-249)
Epitope TSTLQEQIGW Epitope Alignment
TSTLQEQIGW epitope logo
Show epitope variants
Epitope Name TW10
Subtype B
Species (MHC/HLA) human(B*5701)
Immunogen HIV-1 infection
Patient MHC/HLA P1: B*5701; P2: B*5701; P3: B*5701; P4: B*5701; P5: B*5701; P6: B*5701
Country United States
Experimental methods Other
Keywords elite controllers

Notes

References

Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.


Displaying record number 59209

HXB2 Location Gag(308-316)
p24(176-184)
DNA(1711..1737)
Gag Epitope Map
Author Location Gag(308-316)
Epitope QASQEVKNW Epitope Alignment
QASQEVKNW epitope logo
Show epitope variants
Epitope Name QW9
Subtype B
Species (MHC/HLA) human(B*5701)
Immunogen HIV-1 infection
Patient MHC/HLA P1: B*5701; P2: B*5701; P3: B*5701
Country United States
Experimental methods Other
Keywords elite controllers

Notes

References

Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.


Displaying record number 59211

HXB2 Location Nef(82-91)
DNA(9040..9069)
Nef Epitope Map
Author Location Nef(82-91)
Epitope KAALDLSHFL Epitope Alignment
KAALDLSHFL epitope logo
Show epitope variants
Epitope Name KL10
Subtype B
Species (MHC/HLA) human(B*5701)
Immunogen HIV-1 infection
Patient MHC/HLA P2: B*5701; P3: B*5701; P4: B*5701; P6: B*5701
Country United States
Experimental methods Other
Keywords elite controllers

Notes

References

Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.


Displaying record number 59212

HXB2 Location Nef(116-125)
DNA(9142..9171)
Nef Epitope Map
Author Location Nef(116-125)
Epitope HTQGYFPDWQ Epitope Alignment
HTQGYFPDWQ epitope logo
Show epitope variants
Epitope Name HQ10
Subtype B
Species (MHC/HLA) human(B*5701)
Immunogen HIV-1 infection
Patient MHC/HLA P1: B*5701; P2: B*5701; P3: B*5701; P4: B*5701; P5: B*5701; P6: B*5701
Country United States
Experimental methods Other
Keywords elite controllers

Notes

References

Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.


Displaying record number 59213

HXB2 Location Nef(120-128)
DNA(9154..9180)
Nef Epitope Map
Author Location Nef(120-128)
Epitope YFPDWQNYT Epitope Alignment
YFPDWQNYT epitope logo
Show epitope variants
Epitope Name YT9
Subtype B
Species (MHC/HLA) human(B*5701)
Immunogen HIV-1 infection
Patient MHC/HLA P1: B*5701; P2: B*5701; P4: B*5701
Country United States
Experimental methods Other
Keywords elite controllers

Notes

References

Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Operated by Los Alamos National Security, LLC, for the U.S. Department of Energy's National Nuclear Security Administration
Copyright © 2006-2017 LANS LLC All rights reserved | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health